Diamedizen 60 Mr 30 Tab

Diamedizen Mr 60 Mg 30 Tablets

Description:

Diamedizen MR 60 mg is an oral antidiabetic prescription medicine containing gliclazide, a modified-release sulfonylurea used to control blood glucose levels in adults with type 2 diabetes mellitus. It works primarily by stimulating the pancreas to release more insulin and by improving the body’s response to insulin, helping to achieve better glycemic control when diet and exercise alone are insufficient. Each pack contains 30 modified-release film-coated tablets designed for once-daily dosing to provide stable blood sugar control over 24 hours.

Indications:

• Type 2 diabetes mellitus (non–insulin-dependent diabetes) in adults when blood glucose cannot be adequately controlled by diet, physical activity and weight reduction alone.
• Helps reduce elevated fasting and postprandial (after-meal) blood glucose levels.
• May be used as monotherapy or in combination with other oral antidiabetic agents or insulin, as directed by a physician.
• Aims to reduce the risk of long-term diabetes complications associated with poor glycemic control (such as microvascular and macrovascular complications) as part of an overall diabetes management plan.

Active Ingredients / Key Components:

• Gliclazide – 60 mg modified-release (MR) per film-coated tablet.
• Excipients: The full list of inactive ingredients (excipients, coating agents, etc.) is not available in the provided information. Please refer to the official package leaflet for complete excipient details.

Dosage & Administration / How to Use:

• Diamedizen MR 60 mg is for oral use only and is intended for adults with type 2 diabetes.
• Usual starting dose: As determined by the treating physician based on blood glucose levels, previous therapy, and patient profile. A common clinical approach is to start with a lower dose of modified-release gliclazide and titrate gradually; however, the exact starting and maintenance dose for Diamedizen MR 60 mg must be prescribed by your doctor.
• Administration: Take the tablet once daily, preferably with breakfast or the first main meal of the day, to reduce the risk of hypoglycemia and ensure prolonged glucose control.
• Swallow the tablet whole with a sufficient amount of water. Do not crush, chew, or break the tablet, as this will alter the modified-release properties.
• Take the medicine at the same time each day to maintain steady blood levels.
• Do not skip meals while taking gliclazide, as this increases the risk of low blood sugar (hypoglycemia).
• If a dose is missed, take it as soon as you remember on the same day. If it is almost time for the next dose, skip the missed dose and continue with your regular schedule. Do not take a double dose to make up for a missed one.
• Dosage adjustments: Your doctor may adjust the dose based on regular blood glucose monitoring, HbA1c levels, changes in weight, diet, physical activity, or concomitant medications.
• Use only under medical supervision and never change the dose or stop treatment without consulting your healthcare provider.

Clinical Benefits:

• Provides effective blood glucose control in adults with type 2 diabetes when lifestyle measures alone are insufficient.
• Modified-release formulation offers smoother and more sustained 24-hour glycemic control with once-daily dosing.
• Stimulates insulin secretion from pancreatic beta cells and improves tissue sensitivity to insulin, enhancing overall glucose tolerance.
• Helps reduce fasting and post-meal blood sugar levels, supporting better HbA1c outcomes as part of a comprehensive diabetes management plan.
• May contribute to lowering the risk of long-term diabetes-related complications when used consistently alongside diet, exercise, and regular monitoring.

Warnings & Contraindications:

• Contraindicated in patients with type 1 diabetes mellitus, diabetic ketoacidosis, diabetic pre-coma or coma, and severe renal or hepatic impairment (refer to your doctor for specific clinical guidance).
• Do not use if you have known hypersensitivity or allergy to gliclazide, other sulfonylureas, sulfonamides, or any component of the formulation.
• Not recommended in pregnancy or breastfeeding unless clearly advised by a specialist; insulin is usually preferred in these situations.
• Risk of hypoglycemia: Use with caution in elderly patients, those with irregular meal patterns, malnutrition, adrenal or pituitary insufficiency, or when combined with other antidiabetic drugs or alcohol.
• Use with caution in patients with mild to moderate renal or hepatic impairment; dose adjustment and close monitoring may be required.
• Alcohol intake may potentiate the hypoglycemic effect and should be limited or avoided.
• Some medicines can increase or decrease the effect of gliclazide (e.g., other antidiabetics, beta-blockers, ACE inhibitors, corticosteroids, diuretics, certain antibiotics and antifungals). Inform your doctor and pharmacist about all medications and supplements you are taking.
• Hypoglycemia may impair concentration and reaction time; use caution when driving or operating machinery, especially at the start of treatment or after dose changes.
• Consult your doctor before use if pregnant, nursing, planning pregnancy, taking other medications, or if you have medical conditions such as liver disease, kidney disease, adrenal or pituitary disorders, or cardiovascular disease.
• Keep out of reach of children.
• This product is a prescription antidiabetic medicine and must be used only under medical supervision.

Side Effects:

• Common side effects: Hypoglycemia (low blood sugar) with symptoms such as sweating, tremor, hunger, palpitations, headache, dizziness, weakness, irritability, or difficulty concentrating. Mild hypoglycemia can usually be corrected by taking fast-acting carbohydrates (e.g., glucose tablets, sugary drink).
• Gastrointestinal effects: Nausea, vomiting, abdominal pain, indigestion, diarrhea or constipation may occur in some patients.
• Skin reactions: Rash, itching, redness, or urticaria (hives) may occur in cases of hypersensitivity.
• Rare but serious side effects: Severe hypoglycemia, liver function disturbances, blood dyscrasias (e.g., anemia, leukopenia, thrombocytopenia), or severe allergic reactions. Seek immediate medical attention if you experience severe weakness, loss of consciousness, yellowing of the skin or eyes, unusual bleeding or bruising, or difficulty breathing.
• If any side effects persist, worsen, or if you notice any other unusual symptoms, contact your doctor or pharmacist promptly.

Storage Instructions:

Store in a cool, dry place away from direct sunlight and moisture. Keep the tablets in their original blister pack or container, tightly closed, and at a temperature below 30°c or as indicated on the package. Do not use after the expiry date printed on the pack. Keep out of reach of children.

Specifications:

• Product type: Oral antidiabetic prescription medicine (sulfonylurea).
• Strength: 60 mg gliclazide per modified-release film-coated tablet.
• Form: Tablet (modified-release, film-coated).
• Pack size: 30 tablets per pack.
• Intended users: Adults with type 2 diabetes mellitus, as prescribed by a healthcare professional.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.